OPKO Health (NASDAQ: OPK) saw its stock price plummet 5.80% in after-hours trading on Wednesday following the release of its disappointing first-quarter 2025 financial results. The healthcare company's earnings and revenue figures fell short of analyst expectations, raising concerns about its performance.

OPKO Health reported a quarterly loss of $(0.10) per share, missing the analyst consensus estimate of $(0.07) by 42.86%. While this represents a slight improvement from the $(0.12) per share loss in the same period last year, the wider-than-expected loss likely contributed to the stock's decline. The company's revenue also disappointed, coming in at $149.90 million, which fell short of the analyst consensus estimate of $164.26 million by 8.74%. This marks a significant 13.70% decrease compared to the $173.70 million in sales reported for the same period last year.

The company's financial struggles were further highlighted by its reported net income of $(67.6) million for the quarter. OPKO Health's revenue from services, which stood at $102.8 million, suggests that the company is facing challenges in its core business operations. As investors digest these results, the after-hours stock plunge reflects growing concerns about OPKO Health's financial health and future prospects in the competitive healthcare sector.